Juul Labs Secures Strategic Funding to Expand Innovative Nicotine Alternatives for Adult Smokers

We are thrilled to announce that Juul Labs has successfully closed its latest funding round, raising an undisclosed but impactful amount to further propel our mission. As a thriving team of scientists, engineers, designers, and professionals, Juul Labs has long been dedicated to providing adult smokers with alternatives to combustible cigarettes, while rigorously combating underage use of our products. This recent influx of capital will empower us to accelerate our research and development initiatives, broaden our reach in transitioning current smokers, and enhance our state‐of‐the-art manufacturing processes to ensure the highest quality of our JUUL products. Since our inception by co-founders Adam Bowen and James Monsees—who leveraged their years of experience in product design to challenge the tobacco industry—we have remained committed to pioneering revolutionary technology. Our flagship product, featuring a uniquely engineered low-temperature regulation system paired with meticulously formulated e-liquid, delivers a competitive nicotine experience that mirrors combustible cigarette use without many of the associated harms. The funds raised will also support our continuous efforts to improve product safety, education initiatives, and regulatory engagement, all aimed at rebuilding and maintaining trust among our stakeholders and regulators alike. This milestone not only marks a significant step forward for Juul Labs, but also reinforces our commitment to the world’s one billion adult smokers, providing them with a credible alternative when cessation is the ideal goal. We extend our heartfelt gratitude to our investors and partners for believing in our vision and enabling us to further our mission of transforming smoking habits for a healthier future.